Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89


The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer.

Alharbi M, Zuñiga F, Elfeky O, Guanzon D, Lai A, Rice GE, Perrin L, Hooper J, Salomon C.

Endocr Relat Cancer. 2018 Dec 1;25(12):R663-R685. doi: 10.1530/ERC-18-0019. Review.


Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells.

Chen WX, Xu LY, Qian Q, He X, Peng WT, Zhu YL, Cheng L.

Biosci Rep. 2018 Nov 15;38(6). pii: BSR20181090. doi: 10.1042/BSR20181090. Print 2018 Dec 21.


Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.

Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, Tang JH.

PLoS One. 2014 Apr 16;9(4):e95240. doi: 10.1371/journal.pone.0095240. eCollection 2014.


Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.

Sharma A.

Nanomedicine (Lond). 2017 Sep;12(17):2137-2148. doi: 10.2217/nnm-2017-0184. Epub 2017 Aug 14. Review.


Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.

Mao L, Li J, Chen WX, Cai YQ, Yu DD, Zhong SL, Zhao JH, Zhou JW, Tang JH.

Tumour Biol. 2016 Apr;37(4):5247-56. doi: 10.1007/s13277-015-4402-2. Epub 2015 Nov 10.


miRNA expression patterns in chemoresistant breast cancer tissues.

Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.

Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5.


Role of microRNAs in chemoresistance.

Magee P, Shi L, Garofalo M.

Ann Transl Med. 2015 Dec;3(21):332. doi: 10.3978/j.issn.2305-5839.2015.11.32. Review.


Exosome-derived microRNAs contribute to prostate cancer chemoresistance.

Li J, Yang X, Guan H, Mizokami A, Keller ET, Xu X, Liu X, Tan J, Hu L, Lu Y, Zhang J.

Int J Oncol. 2016 Aug;49(2):838-46. doi: 10.3892/ijo.2016.3560. Epub 2016 Jun 3.


Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs.

Chen WX, Cai YQ, Lv MM, Chen L, Zhong SL, Ma TF, Zhao JH, Tang JH.

Tumour Biol. 2014 Oct;35(10):9649-59. doi: 10.1007/s13277-014-2242-0. Epub 2014 Jun 27.


Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.

Santos JC, Ribeiro ML, Sarian LO, Ortega MM, Derchain SF.

Am J Cancer Res. 2016 Oct 1;6(10):2129-2139. eCollection 2016. Review.


Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer.

Panigrahi GK, Ramteke A, Birks D, Abouzeid Ali HE, Venkataraman S, Agarwal C, Vibhakar R, Miller LD, Agarwal R, Abd Elmageed ZY, Deep G.

Oncotarget. 2018 Feb 17;9(17):13894-13910. doi: 10.18632/oncotarget.24532. eCollection 2018 Mar 2.


Clinical relevance of circulating cell-free microRNAs in ovarian cancer.

Nakamura K, Sawada K, Yoshimura A, Kinose Y, Nakatsuka E, Kimura T.

Mol Cancer. 2016 Jun 24;15(1):48. doi: 10.1186/s12943-016-0536-0. Review.


MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes.

Zhong S, Chen X, Wang D, Zhang X, Shen H, Yang S, Lv M, Tang J, Zhao J.

Oncotarget. 2016 Apr 12;7(15):19601-9. doi: 10.18632/oncotarget.7481.


Exosome: a novel mediator in drug resistance of cancer cells.

Zhang HD, Jiang LH, Hou JC, Zhong SL, Zhu LP, Wang DD, Zhou SY, Yang SJ, Wang JY, Zhang Q, Xu HZ, Zhao JH, Ji ZL, Tang JH.

Epigenomics. 2018 Nov;10(11):1499-1509. doi: 10.2217/epi-2017-0151. Epub 2018 Oct 12.


Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo.

Zhang D, Lee H, Zhu Z, Minhas JK, Jin Y.

Am J Physiol Lung Cell Mol Physiol. 2017 Jan 1;312(1):L110-L121. doi: 10.1152/ajplung.00423.2016. Epub 2016 Nov 23.


The role of exosomes and miRNAs in drug-resistance of cancer cells.

Bach DH, Hong JY, Park HJ, Lee SK.

Int J Cancer. 2017 Jul 15;141(2):220-230. doi: 10.1002/ijc.30669. Epub 2017 Mar 11. Review.


Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications.

Sempere LF, Keto J, Fabbri M.

Cancers (Basel). 2017 Jun 24;9(7). pii: E71. doi: 10.3390/cancers9070071. Review.


Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.

Zhao X, Ren Y, Cui N, Wang X, Cui Y.

Medicine (Baltimore). 2018 Sep;97(39):e12632. doi: 10.1097/MD.0000000000012632.


miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.

Corcoran C, Rani S, O'Driscoll L.

Prostate. 2014 Sep;74(13):1320-34. doi: 10.1002/pros.22848. Epub 2014 Jul 22.


MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Matuszcak C, Haier J, Hummel R, Lindner K.

World J Gastroenterol. 2014 Oct 14;20(38):13658-66. doi: 10.3748/wjg.v20.i38.13658. Review.

Supplemental Content

Support Center